S. Kumar's Profile

Role	Title	Level	Year	L/R
🐜	CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma 28 auth. E. Hsi, R. Steinle, B. Balasa, S. Szmania, Aparna Draksharapu, B. Shum, M. Huseni, David M. W. Powers, A. Nanisetti, Yin Zhang, A. Rice, Anne van Abbema, M. Wong, Gao Liu, F. Zhan, ... M. Dillon, Shihao Chen, S. Rhodes, F. Fuh, N. Tsurushita, S. Kumar, V. Vexler, J. Shaughnessy, B. Barlogie, F. van Rhee, M. Hussein, D. Afar, Marna B. Williams	8	2008	8 🐜
🐢	Design of humanized antibodies: from anti-Tac to Zenapax. N. Tsurushita, P. Hinton, S. Kumar	6	2005	6 🐢
🐢	Humanization of a chicken anti-IL-12 monoclonal antibody. 9 auth. N. Tsurushita, Minha Park, Kanokwan Pakabunto, Kelly C. Ong, Ana Avdalovic, H. Fu, ... A. Jia, M. Vásquez, S. Kumar	5	2004	5 🐢
🐜	Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice. 13 auth. N. Bhagavathula, Kamalakar C. Nerusu, G. Fisher, Gao-li Liu, A. Thakur, L. Gemmell, S. Kumar, Zenghai H Xu, P. Hinton, N. Tsurushita, ... N. F. Landolfi, J. Voorhees, J. Varani	5	2005	5 🐜
🐢	LC determination of glimepiride and its related impurities. M. Khan, Sukumar Sinha, S. Vartak, A. Bhartiya, S. Kumar	5	2005	5 🐢
🐜	CS 1 , a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma 28 auth. E. Hsi, R. Steinle, B. Balasa, S. Szmania, Aparna Draksharapu, B. Shum, M. Huseni, David M. W. Powers, A. Nanisetti, Yin Zhang, A. Rice, A. V. Abbema, M. Wong, Gao Liu, F. Zhan, ... M. Dillon, Shihao Chen, S. Rhodes, F. Fuh, N. Tsurushita, S. Kumar, V. Vexler, J. Shaughnessy, B. Barlogie, F. Rhee, MohamadHussein, D. Afar, A. Williams	5	2008	5 🐜
🦁	Crystal packing analysis of 1-(3,4-dimethoxyphenyl)-3-(4-bromophenyl)prop-2-en-1-one exhibiting a putative halogen bond CBr⋯O 10 auth. S. Kumar, Al-Ostoot Fares Hezam, B. Manjunath, V. R. Shamprasad, Y. H. Mohammed, N. Mahesh, ... Zabiulla, A. K. Shaukath, N. K. Lokanath, K. Byrappa	4	2018	4 🦁
🐜	Investigation of 9-(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-en-1-yl)-3,3-dimethyl-2,3,4,9-tetrahydro-1H-xanthen-1-one: Crystal structure, AIM and NBO analysis 7 auth. M. Udayakumar, Kothandapani Jagatheeswaran, S. Ganesan, N. Venkataramanan, S. Kumar, K. Byrappa, ... S. Thamotharan	4	2017	4 🐜
🐬	TBHP Mediated Substrate Controlled Oxidative Dearomatization of Indoles to C2/C3‐Quaternary Indolinones Jagatheeswaran Kothandapani, Singarajanahalli Mundarinti Krishna Reddy, S. Thamotharan, S. Kumar, K. Byrappa, S. Ganesan	4	2018	4 🐬